BIG PHARMA EARNINGS WATCH: MERCK, ELI LILLY, AMGEN, PFIZER, GLAXOSMITHKLINE, ASTRAZENECA

New Earnings Reports Show Big Pharma Giants Continue to Reap Massive Profits, Read More

CSRXP STATEMENT ON CONFIRMATION OF DR. ROBERT CALIFF AS COMMISSIONER OF U.S. FOOD AND DRUG ADMINISTRATION

FDA Can Play a Critical Role in Holding Big Pharma Accountable and Promoting Read More

BIG PHARMA EARNINGS WATCH: ABBVIE, SANOFI, BRISTOL-MYERS SQUIBB, NOVARTIS

New Q4 Earnings Reports Underscore How Big Pharma’s Pandemic Price Hikes, Read More

SECOND OPINION: PHRMA STUDY REHASHES DEBUNKED SUPPLY CHAIN BLAME GAMES

Big Pharma Sidesteps Industry’s Own Price Hikes and Egregious Practices in Read More

CSRXP: BIG PHARMA’S BUSINESS-AS-USUAL APPROACH TO JANUARY PRICE HIKES UNDERSCORES URGENCY FOR RX SOLUTIONS

Drug Companies Increased Prices on 785 Brand Name Products in First Month of Read More

BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON

J&J Surpasses Wall Street Expectations, Nearly Tripling Year-Over-Year Read More

ICYMI: NEW REPORTS UNDERSCORE URGENCY FOR ACTION TO REIN IN BIG PHARMA’S OUT-OF-CONTROL DRUG PRICES

CBO Finds Net Prices for Brand Name Drugs More Than Doubled from 2009-2018; Read More

DOSE OF REALITY: NEW ANALYSIS UNDERSCORES HOW OFTEN BIG PHARMA’S PATENTS ARE UNRELATED TO CLINICAL INNOVATION

Study Finds Just Six Percent of Drug Patents in Infringement Suits Were for Read More

CSRXP STATEMENT ON PROPOSED CMS COVERAGE DECISION FOR ADUHELM

DECISION WILL HELP PROTECT SENIORS, TAXPAYERS AND THE U.S. HEALTH SYSTEM FROM Read More

CSRXP STATEMENT AHEAD OF COMMITTEE VOTE FOR DR. ROBERT CALIFF TO LEAD U.S. FOOD AND DRUG ADMINISTRATION

Next FDA Commissioner Must Promote Competition, Transparency And Value In The Read More

SECOND OPINION: BIG PHARMA CEO CLAIMS “COURAGEOUS” TO PRICE UNPROVEN TREATMENT 10 TIMES ESTIMATE OF FAIR PRICE

Biogen Decision to Change Aduhelm Price After Public Outcry Demonstrates Big Read More